IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,015,311 | +14.0% | 166,172 | +19.2% | 0.04% | +21.2% |
| Q4 2022 | $890,849 | +106.2% | 139,413 | +208.9% | 0.03% | +120.0% |
| Q3 2022 | $432,000 | -79.3% | 45,137 | -64.0% | 0.02% | -81.0% |
| Q1 2022 | $2,085,000 | -4.6% | 125,229 | +9.3% | 0.08% | -7.1% |
| Q4 2021 | $2,186,000 | -20.7% | 114,534 | +2.4% | 0.08% | -15.8% |
| Q3 2021 | $2,758,000 | +131.2% | 111,834 | +143.8% | 0.10% | +274.1% |
| Q2 2021 | $1,193,000 | -81.1% | 45,868 | -77.0% | 0.03% | -86.2% |
| Q1 2021 | $6,308,000 | +31.1% | 199,247 | +92.2% | 0.20% | +23.3% |
| Q4 2020 | $4,810,000 | +130.6% | 103,669 | +63.6% | 0.16% | -42.4% |
| Q3 2020 | $2,086,000 | – | 63,352 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |